New Pharmacological Agents for Arrhythmias
- 1 October 2009
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation: Arrhythmia and Electrophysiology
- Vol. 2 (5), 588-597
- https://doi.org/10.1161/circep.109.884429
Abstract
No abstract availableThis publication has 59 references indexed in Scilit:
- Effect of Dronedarone on Cardiovascular Events in Atrial FibrillationNew England Journal of Medicine, 2009
- Dronedarone for the control of ventricular rate in permanent atrial fibrillation: The Efficacy and safety of dRonedArone for The cOntrol of ventricular rate during atrial fibrillation (ERATO) studyAmerican Heart Journal, 2008
- Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approachesEP Europace, 2008
- Atrial-Selective Approaches for the Treatment of Atrial FibrillationJournal of the American College of Cardiology, 2008
- Drug Therapy for Atrial FibrillationMedical Clinics of North America, 2008
- TrichobezoarNew England Journal of Medicine, 2007
- Dronedarone: An Amiodarone Analog for the Treatment of Atrial Fibrillation and Atrial FlutterAnnals of Pharmacotherapy, 2007
- A Review of the Investigational Antiarrhythmic Agent DronedaroneJournal of Cardiovascular Pharmacology and Therapeutics, 2007
- Drug therapy for atrial fibrillation: where do we go from here?Nature Reviews Drug Discovery, 2005
- Dronedarone for prevention of atrial fibrillation: A dose-ranging studyEuropean Heart Journal, 2003